Royal Prima PT Cash Flow Conversion Efficiency
Royal Prima PT cash flow conversion efficiency. Based on the latest financial reports, Royal Prima PT (PRIM) has a cash flow conversion efficiency ratio of 0.002x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rp1.86 Billion ≈ $108.71K USD) by net assets (Rp955.60 Billion ≈ $55.99 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Royal Prima PT (2014–2024)
Cash flow conversion efficiency of Royal Prima PT from 2014 to 2024. This chart illustrates how Royal Prima PT's cash flow conversion efficiency has evolved over time, based on yearly financial data. View PRIM stock price and chart for real-time trading data and today's change.
Royal Prima PT Cash Flow Conversion Ratio Explained
Royal Prima PT cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Royal Prima PT Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Royal Prima PT ranked by their cash flow conversion efficiency. Also see PRIM market cap overview for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Plaza Wires Limited
NSE:PLAZACABLE
|
-0.026x |
|
MIRA Pharmaceuticals, Inc. Common Stock
NASDAQ:MIRA
|
-0.148x |
|
A SPAC III Acquisition Corp. Class A Ordinary Shares
NASDAQ:ASPC
|
-0.056x |
|
PLB Engineering Bhd
KLSE:7055
|
-0.033x |
|
Promise Technology Inc
TW:3057
|
-0.066x |
|
Conduril - Engenharia S.A
LS:CDU
|
N/A |
|
Eutilex.Co.Ltd
KQ:263050
|
-0.083x |
|
Higgstec
TWO:5220
|
0.008x |
Annual Cash Flow Conversion Efficiency for Royal Prima PT (2014–2024)
The table below shows the annual cash flow conversion efficiency of Royal Prima PT from 2014 to 2024. Review PRIM free cash flow generation to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | Rp962.38 Billion ≈ $56.39 Million |
Rp46.98 Billion ≈ $2.75 Million |
0.049x | +125.21% |
| 2023-12-31 | Rp981.10 Billion ≈ $57.49 Million |
Rp21.27 Billion ≈ $1.25 Million |
0.022x | -1.33% |
| 2022-12-31 | Rp982.66 Billion ≈ $57.58 Million |
Rp21.59 Billion ≈ $1.27 Million |
0.022x | -90.97% |
| 2021-12-31 | Rp964.21 Billion ≈ $56.50 Million |
Rp234.54 Billion ≈ $13.74 Million |
0.243x | +259.56% |
| 2020-12-31 | Rp889.35 Billion ≈ $52.11 Million |
Rp60.16 Billion ≈ $3.53 Million |
0.068x | +1830.15% |
| 2019-12-31 | Rp851.17 Billion ≈ $49.88 Million |
Rp2.98 Billion ≈ $174.81K |
0.004x | -91.58% |
| 2018-12-31 | Rp848.87 Billion ≈ $49.74 Million |
Rp35.33 Billion ≈ $2.07 Million |
0.042x | -53.08% |
| 2017-12-31 | Rp250.42 Billion ≈ $14.67 Million |
Rp22.22 Billion ≈ $1.30 Million |
0.089x | -96.16% |
| 2016-12-31 | Rp12.13 Billion ≈ $710.64K |
Rp28.02 Billion ≈ $1.64 Million |
2.310x | +135.31% |
| 2015-12-31 | Rp722.89 Million ≈ $42.36K |
Rp-4.73 Billion ≈ $-277.14K |
-6.543x | -274.24% |
| 2014-12-31 | Rp-2.10 Billion ≈ $-123.29K |
Rp3.68 Billion ≈ $215.54K |
-1.748x | -- |
About Royal Prima PT
PT Royal Prima Tbk engages in providing hospital services in Indonesia. The company operates its hospitals under the Royal Prima Medan, Royal Prima Jambi, and RSU Royal Prima Marelan names. It provides health services, such as emergency, outpatient, inpatient, laboratorium, radiology, medical rehab, pharmacy, and MCU; and general surgery, internist, VCT, ICU, cardiology, urology, haemodialysis, m… Read more